4.8 Article

DNA vaccination via RALA nanoparticles in a microneedle delivery system induces a potent immune response against the endogenous prostate cancer stem cell antigen

Journal

ACTA BIOMATERIALIA
Volume 96, Issue -, Pages 480-490

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.actbio.2019.07.003

Keywords

DNA vaccine; Microneedle; PSCA; RALA; CTL; Nanoparticle; Prostate cancer

Funding

  1. Prostate Cancer UK Award [S12-006]

Ask authors/readers for more resources

Castrate resistant prostate cancer (CRPC) remains a major challenge for healthcare professionals. Immunotherapeutic approaches, including DNA vaccination, hold the potential to harness the host's own immune system to mount a cell-mediated, anti-tumour response, capable of clearing disseminated tumour deposits. These anti-cancer vaccines represent a promising strategy for patients with advanced disease, however, to date DNA vaccines have demonstrated limited efficacy in clinical trials, owing to the lack of a suitable DNA delivery system. This study was designed to evaluate the efficacy of a two-tier delivery system incorporating cationic RALA/pDNA nanoparticles (NPs) into a dissolvable microneedle (MN) patch for the purposes of DNA vaccination against prostate cancer. Application of NP-loaded MN patches successfully resulted in endogenous production of the encoded Prostate Stem Cell Antigen (PSCA). Furthermore, immunisation with RALA/pPSCA loaded MNs elicited a tumour-specific immune response against TRAMP-C1 tumours ex vivo. Finally, vaccination with RALA/pPSCA loaded MNs demonstrated anti-tumour activity in both prophylactic and therapeutic prostate cancer models in vivo. This is further evidence that this two-tier MN delivery system is a robust platform for prostate cancer DNA vaccination. Statement of Significance This research describes the development and utilisation of our unique microneedle (MN) DNA delivery system, which enables penetration through the stratum corneum and deposition of the DNA within the highly immunogenic skin layers via a dissolvable MN matrix, and facilitates cellular uptake via complexation of pDNA cargo into nanoparticles (NPs) with the RALA delivery peptide. We report for the first time on using the NP-MN platform to immunise mice with encoded Prostate Stem Cell Antigen (mPSCA) for prostate cancer DNA vaccination. Application of the NP-MN system resulted in local mPSCA expression in vivo. Furthermore, immunisation with the NP-MN system induced a tumour-specific cellular immune response, and inhibited the growth of TRAMP-C1 prostate tumours in both prophylactic and therapeutic challenge models in vivo. (C) 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Instruments & Instrumentation

Rapidly dissolving bilayer microneedles enabling minimally invasive and efficient protein delivery to the posterior segment of the eye

Yu Wu, Lalitkumar K. Vora, Ryan F. Donnelly, Thakur Raghu Raj Singh

Summary: In this study, dissolving bilayer microneedles were developed as a safe and effective intraocular protein delivery system for the treatment of retinal vascular disorders.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2023)

Article Engineering, Biomedical

Delivery of a peptide/microRNA blend via electrospun antimicrobial nanofibres for wound repair

Adrian D. Juncos Bombin, Nicholas Dunne, Helen O. McCarthy

Summary: The downregulation of miR-31 and miR-132 is linked to delayed wound healing. In this study, it was hypothesized that delivering miR-31 and miR-132 intracellularly, either individually or in a blend, could enhance tissue repair. The use of a blend formulation can minimize toxicity and maximize therapeutic effects.

ACTA BIOMATERIALIA (2023)

Review Engineering, Biomedical

Where Microneedle Meets Biomarkers: Futuristic Application for Diagnosing and Monitoring Localized External Organ Diseases

Achmad Himawan, Lalitkumar K. Vora, Andi Dian Permana, Sumarheni Sudir, Airin R. Nurdin, Ririn Nislawati, Rafikah Hasyim, Christopher J. Scott, Ryan F. Donnelly

Summary: Extracellular tissue fluids contain important biomarkers, but their accessibility has been a challenge in clinical diagnosis and monitoring. Microneedle technology provides a minimally invasive solution to collect tissue fluid samples and utilize them for disease diagnosis and monitoring.

ADVANCED HEALTHCARE MATERIALS (2023)

Article Pharmacology & Pharmacy

Fluorescence-Coupled Techniques for Determining Rose Bengal in Dermatological Formulations and Their Application to Ex Vivo Skin Deposition Studies

Qonita Kurnia Anjani, Sara Demartis, Fabiana Volpe-Zanutto, Huanhuan Li, Akmal Hidayat Bin Sabri, Elisabetta Gavini, Ryan F. F. Donnelly

Summary: Rose Bengal (RB) is a fluorescent dye used in biomedical applications, especially in dermatology. Advanced delivery systems have been developed to enhance its permeation across the skin. However, there is currently no validated method for quantitatively analyzing RB in the skin. This study proposes fluorescence-based techniques and describes the development and validation of a fluorescence-coupled HPLC method to quantify RB in the skin matrix for the first time. Qualitative analysis using multiphoton microscopy and fluorescence emission spectra provides additional insight into RB's distribution and behavior in different environments.

PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Enhancing Intradermal Delivery of Lidocaine by Dissolving Microneedles: Comparison between Hyaluronic Acid and Poly(Vinyl Pyrrolidone) Backbone Polymers

Delly Ramadon, Lissa Florencia Putri Sutrisna, Yahdiana Harahap, Kurnia Sari Setio Putri, Fathin Ulayya, Pietradewi Hartrianti, Qonita Kurnia Anjani, Ryan F. Donnelly

Summary: This study aimed to formulate and evaluate Lidocaine hydrochloride (LiH)-loaded dissolving microneedles (DMNs) with different polymer bases. Based on the in vitro permeation study, LiH-loaded DMNs with hyaluronic acid (10%) and poly(vinyl pyrrolidone) (25%) were found to deposit in the skin with safe concentrations of the drug permeating into systemic circulation.+/-

PHARMACEUTICS (2023)

Review Biotechnology & Applied Microbiology

Metallic Microneedles for Transdermal Drug Delivery: Applications, Fabrication Techniques and the Effect of Geometrical Characteristics

Nikoletta Sargioti, Tanya J. J. Levingstone, Eoin D. D. O'Cearbhaill, Helen O. O. McCarthy, Nicholas J. J. Dunne

Summary: Current procedures for transdermal drug delivery have limitations in administering nucleic acid and small or large drug molecules, and causing pain and stress for needle phobic individuals. The development of a painless micro-sized device for efficient drug delivery is still needed. Recent advances in 3D printing have made it possible to fabricate metallic microneedle arrays, which have the potential to overcome the limitations of traditional systems. This review summarizes the types and modes of drug delivery of microneedles in transdermal drug delivery, discusses their applications in the treatment of diseases, and explores the fabrication techniques and geometrical characteristics of solid metallic microneedles.

BIOENGINEERING-BASEL (2023)

Article Pharmacology & Pharmacy

Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND)

Marco T. A. Abbate, Inken K. Ramoller, Akmal H. Sabri, Alejandro J. Paredes, Aaron J. Hutton, Peter E. McKenna, Ke Peng, Jessica A. Hollett, Helen O. McCarthy, Ryan F. Donnelly

Summary: HIV/AIDS remains a global public health issue, which can lead to HIV-associated neurocognitive disorder due to the restriction of drugs crossing the blood-brain barrier. The nose-to-brain pathway and facial intradermal injection provide potential solutions to deliver drugs into the central nervous system. Nanoparticles and microneedle arrays are effective in increasing drug delivery via these routes.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2023)

Article Chemistry, Multidisciplinary

Hydrogel-forming microarray patches with solid dispersion reservoirs for transdermal long-acting microdepot delivery of a hydrophobic drug

Yara A. Naser, Ismaiel A. Tekko, Lalitkumar K. Vora, Ke Peng, Qonita K. Anjani, Brett Greer, Christopher Elliott, Helen O. McCarthy, Ryan F. Donnelly

Summary: This study demonstrates the successful transdermal long-acting delivery of the hydrophobic drug atorvastatin (ATR) via hydrogel-forming microarray patches (HF-MAPs) using poly(ethylene)glycol (PEG)-based solid dispersion (SD) reservoirs.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Chemistry, Multidisciplinary

Hydrogel-forming microarray patch mediated transdermal delivery of tetracycline hydrochloride

Li Zhao, Lalitkumar K. Vora, Stephen A. Kelly, Linlin Li, Eneko Larraneta, Helen O. McCarthy, Ryan F. Donnelly

Summary: Antibiotic resistance is a serious health problem and is expected to worsen in the future. Researchers have developed a hydrogel-forming microarray patch system that can deliver antibiotics in a sustained manner.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Engineering, Biomedical

Enzyme-Triggered l-α/d-Peptide Hydrogels as a Long-Acting Injectable Platform for Systemic Delivery of HIV/AIDS Drugs

Sophie M. Coulter, Sreekanth Pentlavalli, Lalitkumar K. Vora, Yuming An, Emily R. Cross, Ke Peng, Kate McAulay, Ralf Schweins, Ryan F. Donnelly, Helen O. McCarthy, Garry Laverty

Summary: Eradicating HIV/AIDS by 2030 is a central goal of the World Health Organization. Patient adherence to complicated dosage regimens remains a key barrier. This paper presents an alternative platform, an injectable in situ forming hydrogel implant to deliver a model antiretroviral drug (zidovudine [AZT]) over 28 days.

ADVANCED HEALTHCARE MATERIALS (2023)

Article Chemistry, Medicinal

Combination of Dissolving Microneedles with Nanosuspension and Co-Grinding for Transdermal Delivery of Ketoprofen

Delly Ramadon, Fathin Ulayya, Annisa Sakinah Qur'ani, Iskandarsyah Iskandarsyah, Yahdiana Harahap, Qonita Kurnia Anjani, Vania Aileen, Pietradewi Hartrianti, Ryan F. F. Donnelly

Summary: This study aimed to develop dissolving microneedles (DMN) containing ketoprofen-loaded nanosuspension (NS) and co-grinding (CG) formulations. The most promising formulations for transdermal delivery of ketoprofen were F5-MN-NS (PVA 5%-PVP 10%) and F11-MN-CG (PVA 7.5%-PVP 15%). These findings suggest that the combination of DMN with nanosuspension or a co-grinding system can effectively enhance the transdermal delivery of ketoprofen.

PHARMACEUTICALS (2023)

Article Chemistry, Multidisciplinary

The osteogenic and angiogenic potential of microRNA-26a delivered via a non-viral delivery peptide for bone repair

Phillip Chambers, Monika Ziminska, Ahmed Elkashif, Jordan Wilson, John Redmond, Antzela Tzagiollari, Cole Ferreira, Auden Balouch, Jasmine Bogle, Seth W. Donahue, Nicholas J. Dunne, Helen O. Mccarthy

Summary: Bone-related injuries and diseases are a common cause of morbidity worldwide. This study demonstrates the potential of using microRNA (miRNA) gene therapy, specifically miR-26a, for bone healing. The researchers found that delivering miR-26a using the peptide RALA was effective in regulating osteogenic signaling in mesenchymal stem cells. They also showed that treating critical bone defects with RALA/miR-26a nanoparticles resulted in increased bone volume, density, and blood vessel formation. These findings highlight the utility of miRNA gene therapy in promoting bone healing, calling for further investigation in in vivo models.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Chemistry, Multidisciplinary

Peptide delivery of a multivalent mRNA SARS-CoV-2 vaccine

Cian M. Mccrudden, Lindsey Bennie, Philip Chambers, Jordan Wilson, Megan Kerr, Monika Ziminska, Hayley Douglas, Sarah Kuhn, Emma Carroll, Garrett O'Brien, Niamh Buckley, Nicholas J. Dunne, Helen O. Mccarthy

Summary: Lipid nanoparticles (LNP) have played a crucial role in the success of mRNA vaccines and have opened up new opportunities for therapeutics. This study investigated the use of RALA-SME nanoparticles, which contained a blend of Spike, Membrane, and Envelope antigens, for immunization. The results showed that RALA-SME induced a robust immune response, with highly significant antigen-specific antibodies and T-cell response. Immunization with RALA-SME derivatives in Syrian Golden hamsters resulted in the production of functional antibodies capable of neutralizing SARS-CoV-2 from different lineages, providing protection against disease.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Materials Science, Biomaterials

Microneedle array patches for sustained delivery of fluphenazine: A micron scale approach for the management of schizophrenia

Juhaina M. Abu Ershaid, Lalitkumar K. Vora, Fabiana Volpe-Zanutto, Akmal H. Sabri, Ke Peng, Qonita K. Anjani, Peter E. Mckenna, Anastasia Ripolin, Eneko Larraneta, Helen O. Mccarthy, Ryan F. Donnelly

Summary: Schizophrenia is a severe mental illness characterized by impaired emotion and cognition. Injectable antipsychotics, although designed to enhance adherence, are invasive and require professional administration. To overcome these issues, research has focused on developing transdermal antipsychotic formulations.

BIOMATERIALS ADVANCES (2023)

Article Instruments & Instrumentation

The promise of microneedle technologies for drug delivery

Ryan F. Donnelly, Mark R. Prausnitz

Summary: Microneedle (MN) technologies offer the opportunity to improve drug delivery and treatment by targeting specific tissues. Hollow MNs have been FDA-approved for targeted drug delivery to skin-resident immune cells and specific parts of the eye. MN technology also has applications in cosmetic products. With further research and approved products, MN technology shows promising growth potential.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2023)

No Data Available